Literature DB >> 21671366

Neurocognitive deficits in children with sickle cell disease are associated with the severity of anemia.

Channa T Hijmans1, Martha A Grootenhuis, Jaap Oosterlaan, Harriët Heijboer, Marjolein Peters, Karin Fijnvandraat.   

Abstract

BACKGROUND: Although neurocognitive deficits in children with sickle cell disease (SCD) have been well documented, the etiology of these deficits has not been completely clarified. The aim of this study was to investigate the association of laboratory markers of disease severity and radiological parameters with neurocognitive functioning in children with SCD. DESIGN AND METHODS: Participants were 37 children with SCD ((HbSS or HbS-β(0)-thalassemia) aged 6-18 years. All participants underwent extensive neurocognitive assessment. Further data (TCD values, laboratory test results, and MRI data) were obtained from medical charts. Associations were analyzed by hierarchical regression analysis.
RESULTS: Hemoglobin was associated with a decrease in verbal short-term memory. There was no association between TCD velocities and neurocognitive functioning, when controlled for age. Children with silent infarcts did not differ from children with normal MRI in neurocognitive functioning. Children with right-left asymmetries in cerebral blood flow as measured by continuous arterial spin labelling (CASL) MRI had better sustained attention than children without asymmetries.
CONCLUSIONS: Neurocognitive deficits are associated with the severity of anemia, indicating reduced oxygen delivery to the brain as an etiological mechanism. This implies that children with SCD and normal MRIs may still suffer from neurocognitive impairments, possibly affecting their academic development and full participation in society.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21671366     DOI: 10.1002/pbc.22892

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  22 in total

1.  Cognitive functioning in children from Nigeria with sickle cell anemia.

Authors:  Olubusola B Oluwole; Robert B Noll; Daniel G Winger; Olu Akinyanju; Enrico M Novelli
Journal:  Pediatr Blood Cancer       Date:  2016-07-09       Impact factor: 3.167

2.  White matter damage in asymptomatic patients with sickle cell anemia: screening with diffusion tensor imaging.

Authors:  B Sun; R C Brown; L Hayes; T G Burns; J Huamani; D J Bearden; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-17       Impact factor: 3.825

3.  Differences in Activation and Deactivation in Children with Sickle Cell Disease Compared with Demographically Matched Controls.

Authors:  B Sun; R C Brown; T G Burns; D Murdaugh; S Palasis; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

4.  Correlates of Cognitive Function in Sickle Cell Disease: A Meta-Analysis.

Authors:  Kemar V Prussien; Rachel E Siciliano; Abagail E Ciriegio; Allegra S Anderson; Radha Sathanayagam; Michael R DeBaun; Lori C Jordan; Bruce E Compas
Journal:  J Pediatr Psychol       Date:  2020-03-01

5.  Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.

Authors:  Allison A King; Mark J Rodeghier; Julie Ann Panepinto; John J Strouse; James F Casella; Charles T Quinn; Michael M Dowling; Sharada A Sarnaik; Alexis A Thompson; Gerald M Woods; Caterina P Minniti; Rupa C Redding-Lallinger; Melanie Kirby-Allen; Fenella J Kirkham; Robert McKinstry; Michael J Noetzel; Desiree A White; Janet K Kwiatkowski; Thomas H Howard; Karen A Kalinyak; Baba Inusa; Melissa M Rhodes; Mark E Heiny; Ben Fuh; Jason M Fixler; Mae O Gordon; Michael R DeBaun
Journal:  Am J Hematol       Date:  2014-08-04       Impact factor: 10.047

6.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

7.  Adults with sickle cell disease may perform cognitive tests as well as controls when processing speed is taken into account: a preliminary case-control study.

Authors:  Regina D Crawford; Charles R Jonassaint
Journal:  J Adv Nurs       Date:  2015-08-20       Impact factor: 3.187

Review 8.  Hypoxia and inflammation in children with sickle cell disease: implications for hippocampal functioning and episodic memory.

Authors:  Mary Iampietro; Tania Giovannetti; Reem Tarazi
Journal:  Neuropsychol Rev       Date:  2014-04-18       Impact factor: 7.444

9.  Risk and resilience factors for grade retention in youth with sickle cell disease.

Authors:  Rebecca J Ladd; Cecelia R Valrie; Christy M Walcott
Journal:  Pediatr Blood Cancer       Date:  2014-02-12       Impact factor: 3.167

10.  Association of social-environmental factors with cognitive function in children with sickle cell disease.

Authors:  Janet Yarboi; Bruce E Compas; Gene H Brody; Desiree White; Jenny Rees Patterson; Kristen Ziara; Allison King
Journal:  Child Neuropsychol       Date:  2015-11-15       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.